Speaker(s): 

 Waleed Zafar, MD, Associate, Department of Hospital Medicine; Investigator, Center for Kidney Health Research and Department of Investigational Medicine, Geisinger, has no disclosures to report.  
 
Learning Objectives: 

At the conclusion of this session, the participant should be able to: 

1.Recognize the CKD detection gap.

•Identify barriers to early CKD diagnosis and albuminuria screening in routine practice

2.Evaluate Clinical Decision Support (CDS) tools for CKD identification.

•Compare two clinical decision support tools used to improve albuminuria screening rates at Geisinger

•Describe the design and impact of EHR autoloading of CKD diagnoses to the patient problem list at Geisinger

3.Discuss different tools for CKM syndrome management.

•Outline future applications of CDS in combination with other tools for better management of CKM syndrome

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Candice Laubach, MBA, Christa Martin, PhD, Jennifer Nunamaker, Christian Lynch, MPH, Adam Buchanan, MS, MPH, CGC, and David Rolston, MD, FACP have no identified disclosures. 

The Planning Committee member consisting of Eric Wright, PharmD, MPH has identified disclosures: Consultant/Advisor with AstraZeneca.

CE Committee Member/Content Reviewers have nothing to disclose. 
 
Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPAA compliant. 

Commercial Support for this Session

None

Session date: 
08/19/2026 - 12:00pm to 1:00pm EDT
Location: 
Virtual via Microsoft Teams
PA
United States
See map: Google Maps
Add to calendar: 
  • 1.00 ACPE
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation Credit
Please login or register to take this course.